Cargando…
Association of The Common CYP1A1*2C Variant (Ile462Val Polymorphism) with Chronic Myeloid Leukemia (CML) in Patients Undergoing Imatinib Therapy
OBJECTIVE: Cytochrome P450 is one of the major drug metabolizing enzyme families and its role in metabolism of cancer drugs cannot be less emphasized. The association be- tween single nucleotide polymorphisms (SNPs) in CYP1A1 and pathogenesis of chronic myeloid leukemia (CML) has been investigated i...
Autores principales: | Lakkireddy, Samyuktha, Aula, Sangeetha, AVN, Swamy, Kapley, Atya, Rao Digumarti, Raghunadha, Jamil, Kaiser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601872/ https://www.ncbi.nlm.nih.gov/pubmed/26464823 |
Ejemplares similares
-
CYP1A1 Ile462Val polymorphism and colorectal cancer risk in Polish patients
por: Gil, Justyna, et al.
Publicado: (2014) -
CYP1A1 Ile462Val Polymorphism as a Risk Factor in Cervical Cancer Development in the Polish Population
por: Roszak, Andrzej, et al.
Publicado: (2014) -
MspI and Ile462Val Polymorphisms in CYP1A1 and Overall Cancer Risk: A Meta-Analysis
por: Wu, Bin, et al.
Publicado: (2013) -
CYP1A1 Ile462Val Polymorphism Is Associated with Cervical Cancer Risk in Caucasians Not Asians: A Meta-Analysis
por: Wang, Li-Na, et al.
Publicado: (2017) -
The association of the CYP1A1 Ile462Val polymorphism with head and neck cancer risk: evidence based on a cumulative meta-analysis
por: Wang, Yadong, et al.
Publicado: (2016)